Table II.
Risk scores/clinical characteristics | Hazard ratio | Lower.95 | Upper.95 | P-value |
---|---|---|---|---|
Risk score | 2.718 | 1.720 | 4.297 | <0.001 |
Neoplasm recurrence | 2.479 | 1.594 | 3.856 | <0.001 |
TNM stage | 2.254 | 1.402 | 3.625 | <0.001 |
Tobacco smoking history | 0.633 | 0.421 | 0.951 | 0.028 |
M stage | 3.637 | 1.137 | 11.635 | 0.030 |
T stage | 1.663 | 1.030 | 2.686 | 0.038 |
Target molecular therapy | 0.689 | 0.409 | 1.160 | 0.161 |
Residual tumor | 1.215 | 0.821 | 1.799 | 0.331 |
Radiotherapy | 1.349 | 0.731 | 2.489 | 0.338 |
N stage | 1.188 | 0.781 | 1.806 | 0.421 |
Gender | 1.200 | 0.744 | 1.935 | 0.455 |
Age | 1.016 | 0.671 | 1.538 | 0.939 |
T, tumor; N, node; M, metastasis.